Oncology

 

Part B

 

L29053 ALDESLEUKIN (PROLEUKIN®, INTERLEUKIN-2,

RECOMBINANT, AND RIL-2)

 

L29055 ALEMTUZUMAB (CAMPATH®)

 

L29063 AZACITIDINE (VIDAZA®)

 

L32493 BENDAMUSTINE HYDROCHLORIDE (TREANDA®)

 

L29087 BORTEZOMIB (VELCADE®)

 

L29089 CARBOPLATIN (PARAPLATIN®, PARAPLATIN-AQ®)

 

L29097 CETUXIMAB (ERBITUX®)

 

L29129 DENILEUKIN DIFTITOX (ONTAK®)

 

L29155 DOCETAXEL (TAXOTERE®)

 

L29156 DOXORUBICIN HCL

 

L29157 DOXORUBICIN, LIPOSOMAL (DOXIL/LIPODOX)

 

L29166 EPIRUBICIN HYDROCHLORIDE (ELLENCE™)

 

L29169 ETOPOSIDE (ETOPOPHOS®, TOPOSAR®, VEPESID®, VP-16)

 

L29175 FLOXURIDINE (FUDR)

 

L29176 FLUDARABINE (FLUDARA®)

 

L29178 FULVESTRANT (FASLODEX®)

 

L29182 GEMCITABINE (GEMZAR®)

 

L29183 GEMTUZUMAB OZOGAMICIN (MYLOTARG TM) *

 

L29184 GENE EXPRESSION PROFILING PANEL FOR USE IN THE MANAGEMENT OF BREAST CANCER TREATMENT *

 

L29193 IBRITUMOMAB TIUXETAN (ZEVALIN ®) THERAPY

 

L29208 IRINOTECAN (CAMPTOSAR®)

 

L29213 LEUCOVORIN (WELLCOVORIN®)

 

L29228 MITOMYCIN (MUTAMYCIN®, MITOMYCIN-C)

 

L29229 MITOXANTRONE HYDROCHLORIDE

 

L29248 OXALIPLATIN (ELOXATIN)

 

L29243 OPRELVEKIN (NEUMEGA®)

 

L29249 PACLITAXEL (TAXOL®)

 

L29254 PEGFILGRASTIM (NEULASTA TM)

 

L29255 PEMETREXED

 

L29260  PORFIMER (PHOTOFRIN®)

 

L29271 RITUXIMAB (RITUXAN®)

 

L29290 TOPOTECAN HYDROCHLORIDE (HYCAMTIN®)

 

L29291 TOSITUMOMAB AND IODINE I 131 TOSITUMOMAB (BEXXAR®) THERAPY

 

L29297 TRASTUZUMAB (HERCEPTIN®)

 

L29306 VINORELBINE TARTRATE (NAVELBINE®)

 

 

Part A

 

L28758 ALDESLEUKIN (PROLEUKIN®, INTERLEUKIN-2, RECOMBINANT, AND RIL-2)

 

L28777 ALEMTUZUMAB (CAMPATH®)

 

L28780 AZACITIDINE (VIDAZA®)

 

L32495 BENDAMUSTINE HYDROCHLORIDE (TREANDA®)

 

L28787 BORTEZOMIB (VELCADE®)

 

L28791 CARBOPLATIN (PARAPLATIN®, PARAPLATIN-AQ®)

 

L28802 CETUXIMAB (ERBITUX®)

 

L28820 DENILEUKIN DIFTITOX (ONTAK®)

 

L28825 DOCETAXEL (TAXOTERE®)

 

L28826 DOXORUBICIN HCL

 

L28827 DOXORUBICIN, LIPOSOMAL (DOXIL/LIPODOX)

 

L28835 EPIRUBICIN HYDROCHLORIDE (ELLENCE™)

 

L28837 ETOPOSIDE (ETOPOPHOS®, TOPOSAR®, VEPESID®, VP-16)

 

L28841 FLOXURIDINE (FUDR)

 

L28842 FLUDARABINE (FLUDARA®)

 

L28844 FULVESTRANT (FASLODEX®)

 

L28847 GEMCITABINE (GEMZAR®)

 

L28848 GEMTUZUMAB OZOGAMICIN (MYLOTARG TM) *

 

L28849 GENE EXPRESSION PROFILING PANEL FOR USE IN THE MANAGEMENT OF BREAST CANCER TREATMENT *

 

L28897 IRINOTECAN (CAMPTOSAR®)

 

L28899 LEUCOVORIN (WELLCOVORIN®)

 

L28930 MITOMYCIN (MUTAMYCIN®, MITOMYCIN-C)

 

L28931 MITOXANTRONE HYDROCHLORIDE

 

L28942 OXALIPLATIN (ELOXATIN)

 

L28943 PACLITAXEL (TAXOL®)

 

L28946 PEGFILGRASTIM (NEULASTA TM)

 

L28947 PEMETREXED

 

L28949  PORFIMER (PHOTOFRIN®)

 

L28980 RITUXIMAB (RITUXAN®)

 

L28993 TOPOTECAN HYDROCHLORIDE (HYCAMTIN®)

 

L28994 TOSITUMOMAB AND IODINE I 131 TOSITUMOMAB (BEXXAR®) THERAPY

 

L28998 TRASTUZUMAB (HERCEPTIN®)

 

L29004 VINORELBINE TARTRATE (NAVELBINE®)

 

 

NCDs

 

NCD110.2 CERTAIN DRUGS DISTRIBUTED BY THE NATIONAL CANCER INSTITUTE

 

NCD110.19 ABARELIX FOR THE TREATMENT OF PROSTATE CANCER

 

NCD110.21 ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN CANCER AND RELATED NEOPLASTIC CONDITIONS